Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Endocrinol (Lausanne) ; 13: 968239, 2022.
Article in English | MEDLINE | ID: mdl-36171906

ABSTRACT

Purpose: Very low-calorie restriction (VLCR) can induce remission of type 2 diabetes mellitus (T2DM), but its long-term remission and related predictors have not been clarified. The aim of present study is to investigate the effect of VLCR in inducing long-term T2DM remission, and the underlying predictors. Methods: A total of 61 participants with T2DM who received 9 days of VLCR from Dec 2012 to Oct 2020 were followed up in Nov 2021, and divided into responders and non-responders groups. Responders were defined as HbA1c < 6.5% over at least 3 months in the absence of pharmacotherapy. Clinical characteristics were compared between responders and non-responders. Potential predictors were examined by logistic regression analyses based on clinical data before and after VLCR. Results: Forty-four participants were successfully followed up, including 19 males and 25 females. Long-term remission was observed in 17 participants (38.64%) after VLCR, with a median 7.83 years. Compared with non-responders, responders had a shorter disease duration, a lower fasting blood glucose (FBG) level, a higher fasting insulin level, and better HOMA-ß after VLCR. Besides, acute insulin response (AIR), insulin area under curve in intravenous and oral glucose tolerance test (IVGTT-IAUC and OGTT-IAUC) in responders were higher than those in non-responders after VLCR. Multivariable logistic analysis showed that higher post-VLCR IVGTT-IAUC predicted a longer T2DM remission. Conclusions: After VLCR, more than one third of the participants presented remission over up to 8 years. The improvement of ß-cell function, especially the restoration of first-phase insulin-secreting capacity, could prolongate the remission.


Subject(s)
Diabetes Mellitus, Type 2 , Blood Glucose , Caloric Restriction , Diabetes Mellitus, Type 2/drug therapy , Female , Glycated Hemoglobin , Humans , Insulin , Male
2.
Chem Commun (Camb) ; 47(12): 3607-9, 2011 Mar 28.
Article in English | MEDLINE | ID: mdl-21301723

ABSTRACT

cis-2,3-Dihydro-4-perfluoroalkyl-1H-1,5-benzodiazepines were stereoselectively synthesized using a one-pot, catalyst-free, three-component reaction. This novel, efficient and convenient approach was used to synthesize 22 related products in moderate to excellent yields, demonstrating the scope and potential economic impact of the reaction.


Subject(s)
Benzodiazepines/chemistry , Benzodiazepines/chemical synthesis , Alkylation , Halogenation , Stereoisomerism , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...